Авторы: Рыбкина Е. П., Чистяков И. Н.

Рубрика: Тезисы

Опубликовано в Биоэкономика и экобиополитика №1 (1) декабрь 2015 г.

Дата публикации: 15.01.2016

Статья просмотрена: 2 раза

Библиографическое описание:

Рыбкина Е. П., Чистяков И. Н. Site Management Organizations in Non-Clinical Studies // Биоэкономика и экобиополитика. — 2015. — №1.



 

Biopharmaceuticals industry imperatives demands a systematic approach to preclinical research that starts with predefined objectives and emphasizes processes, systems, and process control based on quality risk management. Centralized management of business and operational functions intended to control the quality and performance of work from the very beginning of the planning phase, usage entire quality metrics relating to preclinical research safety, risk, and conduct standards, generalized for the group of Investigational Sites allows to maintain required level of quality of study results, reduces data bias, monitoring and management burdens while facilitating trial supply and documentation. The survey is aimed to provide a summary of the modern market situation, SMO definitions and Preclinical Study Centre roles and responsibilities within the Pushchino Scientific Center and the biotechnological regional innovation cluster network.

Основные термины (генерируются автоматически): preclinical research safety, Preclinical Study Centre, Biopharmaceuticals industry imperatives, quality risk management, Pushchino Scientific Center, entire quality metrics, biotechnological regional innovation, modern market situation, SMO definitions, systematic approach, management burdens, Investigational Sites, data bias, operational functions, planning phase, conduct standards, cluster network, study results, trial supply, responsibilities.

Обсуждение

Социальные комментарии Cackle

Посетите сайты наших проектов

Задать вопрос